These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 28609209)

  • 1. Creation of a human T-ALL cell line online database.
    Squiban B; Ahmed ST; Frazer JK
    Leuk Lymphoma; 2017 Nov; 58(11):2728-2730. PubMed ID: 28609209
    [No Abstract]   [Full Text] [Related]  

  • 2. T-lymphoblastic leukaemia/lymphoma with rosettes and gland-like structures.
    Yang Y; Juskevicius R
    Br J Haematol; 2020 Oct; 191(2):141. PubMed ID: 32634863
    [No Abstract]   [Full Text] [Related]  

  • 3. Rectal involvement in pre-early T acute lymphoblastic leukemia.
    Massaiu R; Longu F; Podda L; Mura F; Caocci G; La Nasa G; Fara AM; Deiana A; Cossu AGM; Crivelli P; Conti M; Pala C; Carboni L; Scognamillo F; Fozza C
    Ann Hematol; 2020 May; 99(5):1151-1152. PubMed ID: 32179989
    [No Abstract]   [Full Text] [Related]  

  • 4. Elucidation of the methods used for quantitative analysis of radiolabeled sphingolipids with beta imager 2000 radiochromatoscanner in MOLT-4 leukemic cells.
    Venerando B
    Int J Cancer; 2017 Jun; 140(12):2831-2832. PubMed ID: 28340514
    [No Abstract]   [Full Text] [Related]  

  • 5. T-cell lymphoblastic lymphoma of the sternum.
    Zareifar S; Bordbar MR; Karimi M; Geramizadeh B; Rasekhi AR
    J Clin Oncol; 2010 Feb; 28(4):e51-3. PubMed ID: 19917834
    [No Abstract]   [Full Text] [Related]  

  • 6. Concurrent thymoma, thymic carcinoma, and T lymphoblastic leukemia/lymphoma in an anterior mediastinal mass.
    Ito J; Yoshida A; Maeshima AM; Nakagawa K; Watanabe S; Kobayashi Y; Fukuhara S; Tsuta K
    Pathol Res Pract; 2015 Sep; 211(9):693-6. PubMed ID: 26150396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Primary ovarian precursor T-lymphoblastic lymphoma: report of a case].
    Liu XY; Zhong SJ; Mi XJ; Chen ZQ; Huang YX; Chen YY
    Zhonghua Bing Li Xue Za Zhi; 2012 Dec; 41(12):850-1. PubMed ID: 23324239
    [No Abstract]   [Full Text] [Related]  

  • 8. Senescent stromal cell-induced divergence and therapeutic resistance in T cell acute lymphoblastic leukemia/lymphoma.
    Habiel DM; Krepostman N; Lilly M; Cavassani K; Coelho AL; Shibata T; Elenitoba-Johnson K; Hogaboam CM
    Oncotarget; 2016 Dec; 7(50):83514-83529. PubMed ID: 27835864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD90 and CD110 correlate with cancer stem cell potentials in human T-acute lymphoblastic leukemia cells.
    Yamazaki H; Nishida H; Iwata S; Dang NH; Morimoto C
    Biochem Biophys Res Commun; 2009 May; 383(2):172-7. PubMed ID: 19341705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lymphoblastic lymphoma and acute lymphoblastic leukemia: a clinicopathologic, immunophenotypic and prognostic study in 153 Chinese patients].
    Pan Y; Li GD; Liu WP; Zhang WY; Tang Y; Li FY
    Zhonghua Bing Li Xue Za Zhi; 2009 Dec; 38(12):810-5. PubMed ID: 20193455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression profiling of transcription factors in B- or T-acute lymphoblastic leukemia/lymphoma and burkitt lymphoma: usefulness of PAX5 immunostaining as pan-Pre-B-cell marker.
    Nasr MR; Rosenthal N; Syrbu S
    Am J Clin Pathol; 2010 Jan; 133(1):41-8. PubMed ID: 20023257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triphenotypic acute leukemia with TRAP-positive blasts: A pathological rarity.
    Sharma P; Asthana B; Tyagi S
    Leuk Res; 2009 Jul; 33(7):e83-4. PubMed ID: 19237193
    [No Abstract]   [Full Text] [Related]  

  • 13. T-ALL: Home Is where the CXCL12 Is.
    de Bock CE; Cools J
    Cancer Cell; 2015 Jun; 27(6):745-6. PubMed ID: 26058071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Speed of leukemia development and genetic diversity in xenograft models of T cell acute lymphoblastic leukemia.
    Poglio S; Lewandowski D; Calvo J; Caye A; Gros A; Laharanne E; Leblanc T; Landman-Parker J; Baruchel A; Soulier J; Ballerini P; Clappier E; Pflumio F
    Oncotarget; 2016 Jul; 7(27):41599-41611. PubMed ID: 27191650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCR4 Is Required for Leukemia-Initiating Cell Activity in T Cell Acute Lymphoblastic Leukemia.
    Passaro D; Irigoyen M; Catherinet C; Gachet S; Da Costa De Jesus C; Lasgi C; Tran Quang C; Ghysdael J
    Cancer Cell; 2015 Jun; 27(6):769-79. PubMed ID: 26058076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleostemin knocking-down causes cell cycle arrest and apoptosis in human T-cell acute lymphoblastic leukemia MOLT-4 cells via p53 and p21Waf1/Cip1 up-regulation.
    Rahmati M; Moosavi MA; Zarghami N
    Hematology; 2014 Dec; 19(8):455-62. PubMed ID: 24628257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic Mechanisms of Drug Resistance in Leukemia.
    Knoechel B; Aster JC
    Cell Metab; 2015 Nov; 22(5):759-60. PubMed ID: 26536486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of Lhx2 suppresses proliferation of human T cell acute lymphoblastic leukemia-derived cells, partly by reducing LMO2 protein levels.
    Miyashita K; Kitajima K; Goyama S; Kitamura T; Hara T
    Biochem Biophys Res Commun; 2018 Jan; 495(3):2310-2316. PubMed ID: 29278703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone deacetylase inhibitors synergistically potentiate death receptor 4-mediated apoptotic cell death of human T-cell acute lymphoblastic leukemia cells.
    Sung ES; Kim A; Park JS; Chung J; Kwon MH; Kim YS
    Apoptosis; 2010 Oct; 15(10):1256-69. PubMed ID: 20582477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In silico and preclinical drug screening identifies dasatinib as a targeted therapy for T-ALL.
    Laukkanen S; Grönroos T; Pölönen P; Kuusanmäki H; Mehtonen J; Cloos J; Ossenkoppele G; Gjertsen B; Øystein B; Heckman C; Heinäniemi M; Kontro M; Lohi O
    Blood Cancer J; 2017 Sep; 7(9):e604. PubMed ID: 28885610
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.